2001
DOI: 10.1007/s002100100450
|View full text |Cite
|
Sign up to set email alerts
|

Modulation of the cardiac autonomic transmission of pithed rats by presynaptic opioid OP 4 and cannabinoid CB 1 receptors

Abstract: We studied the effects of nociceptin, the endogenous ligand of the opioid OP4 receptor, and of two cannabinoid receptor agonists WIN 55,212-2 and CP-55,940 (0.001-1 micromol/kg each) on the neurogenic tachycardia and bradycardia in pithed rats. Electrical stimulation (1 Hz, 1 ms, 50 V for 10 s) of the preganglionic sympathetic nerve fibres and injection of nicotine 2 micromol/kg or isoprenaline 0.5 nmol/kg increased heart rate by about 70 beats/min (bpm) in pithed rats pretreated with atropine 1.5-2 micromol/k… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
39
0
3

Year Published

2003
2003
2016
2016

Publication Types

Select...
8
1

Relationship

3
6

Authors

Journals

citations
Cited by 44 publications
(46 citation statements)
references
References 19 publications
4
39
0
3
Order By: Relevance
“…Thus, the inhibitory influence of LPS on the neurogenic vasopressor response was abolished by the CB 1 receptor antagonist SR 141716A. The latter drug was used at a dose of 100 nmol kg À1 previously shown to counteract the inhibitory action of the cannabinoid receptor agonists WIN 55,212-2 and CP-55,940 on the neurogenic tachycardia in pithed rats (Malinowska et al, 2001b). SR 141716A has frequently been shown to cause effects opposite to those of cannabinoid receptor agonists and the possibility that this drug abolished the inhibitory effect of LPS on the neurogenic vasopressor response due to a facilitatory effect on this parameter had to be considered.…”
Section: G Godlewski Et Almentioning
confidence: 99%
“…Thus, the inhibitory influence of LPS on the neurogenic vasopressor response was abolished by the CB 1 receptor antagonist SR 141716A. The latter drug was used at a dose of 100 nmol kg À1 previously shown to counteract the inhibitory action of the cannabinoid receptor agonists WIN 55,212-2 and CP-55,940 on the neurogenic tachycardia in pithed rats (Malinowska et al, 2001b). SR 141716A has frequently been shown to cause effects opposite to those of cannabinoid receptor agonists and the possibility that this drug abolished the inhibitory effect of LPS on the neurogenic vasopressor response due to a facilitatory effect on this parameter had to be considered.…”
Section: G Godlewski Et Almentioning
confidence: 99%
“…Despite their unique and cellular/tissue/system-dependent pharmacological profile, it remains to be established how NOP receptor partial agonists affect cardiovascular and renal function in conscious rats compared with the native ligand N/OFQ. This is of particular interest since NOP receptors that are expressed in both central (brain and spinal cord) and peripheral tissues (vasculature, kidneys, heart, sympathetic, and parasympathetic nerve terminals) (Mollereau and Mouledeous, 2000;Malinowska et al, 2001Malinowska et al, , 2000b) may be affected differently by various classes of NOP receptor ligands (e.g., N/OFQ and NOP receptor partial agonists) to influence cardiovascular and renal function.…”
mentioning
confidence: 99%
“…Our approach to this first aim, which, in fact, covered a major part of our study, was based on a report by Malinowska et al (2001b). In that investigation, the electrically and NICevoked tachycardic response was determined in pentobarbitone-anesthetized and vagotomized pithed rats treated with atropine, and the operation of presynaptic CB 1 receptors on postganglionic sympathetic nerve fibers in vivo was proven using synthetic cannabinoids to stimulate these receptors.…”
Section: Discussionmentioning
confidence: 99%
“…All experiments were performed according to Malinowska et al (2001b). They were initiated by the injection of pancuronium (0.8 mol/kg i.v.)…”
Section: Methodsmentioning
confidence: 99%